BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,002,200 | -94.9% | 20,000 | +1930.5% | 0.34% | +66.5% |
| Q2 2022 | $19,500,000 | +2113.4% | 985 | -94.9% | 0.20% | +2.0% |
| Q1 2022 | $881,000 | -57.8% | 19,500 | 0.0% | 0.20% | -57.2% |
| Q4 2021 | $2,089,000 | +4.3% | 19,500 | 0.0% | 0.46% | -3.7% |
| Q3 2021 | $2,003,000 | +16.8% | 19,500 | 0.0% | 0.48% | +6.6% |
| Q2 2021 | $1,715,000 | -9.5% | 19,500 | 0.0% | 0.45% | -9.6% |
| Q1 2021 | $1,896,000 | -13.3% | 19,500 | 0.0% | 0.50% | -16.1% |
| Q4 2020 | $2,187,000 | +21.0% | 19,500 | 0.0% | 0.60% | +2.2% |
| Q3 2020 | $1,808,000 | +96.9% | 19,500 | +62.5% | 0.58% | +91.5% |
| Q2 2020 | $918,000 | +31.1% | 12,000 | 0.0% | 0.30% | -4.4% |
| Q1 2020 | $700,000 | -48.6% | 12,000 | -29.4% | 0.32% | -35.0% |
| Q4 2019 | $1,362,000 | +9.0% | 17,000 | 0.0% | 0.49% | -15.1% |
| Q3 2019 | $1,250,000 | -22.1% | 17,000 | 0.0% | 0.58% | -2.9% |
| Q2 2019 | $1,604,000 | – | 17,000 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 379,090 | $19,037,900 | 17.25% |
| DAFNA Capital Management LLC | 249,521 | $12,530,945 | 3.90% |
| Rock Springs Capital Management LP | 2,685,294 | $134,855,465 | 3.61% |
| Casdin Capital, LLC | 371,378 | $18,650,603 | 2.06% |
| Novo Holdings A/S | 525,000 | $26,365,500 | 1.95% |
| CHI Advisors LLC | 92,888 | $4,664,835 | 1.85% |
| SECTORAL ASSET MANAGEMENT INC | 165,890 | $8,330,996 | 1.62% |
| Avidity Partners Management LP | 751,600 | $37,745,352 | 1.52% |
| EMERALD ADVISERS, LLC | 607,037 | $30,485,393 | 1.48% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 464,321 | $23,318,201 | 1.41% |